{"url_path":"/sec/ccrn/10-q/2026/item-4","section_key":"item-4","section_title":"Item 4 CONTROLS AND PROCEDURES","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","accession_number":"0001628280-26-032542","cik":"0001141103","ticker":"CCRN","issuer_name":"CROSS COUNTRY HEALTHCARE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","primary_entity_key":"0001141103","primary_entity_name":"CROSS COUNTRY HEALTHCARE INC"},"word_count":258,"has_tables":true,"body_markdown":"ITEM 4.    CONTROLS AND PROCEDURES\n\nWe carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report. Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, communicated to management, including the Chief Executive Officer and the Chief Financial Officer, and reported within the time periods specified in the SEC’s rules and forms. The disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports required under the Exchange Act is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, in order to allow timely decisions regarding any required disclosure.\n\nThere were no changes in our internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.\n\n31\n\nPART II. – OTHER INFORMATION"}